SCHEMBL106820

SCHEMBL106820

CCCC(C)[NH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL567526 1.00
SCHEMBL566852 1.00
SCHEMBL105431 0.79
SCHEMBL276895 0.76
SCHEMBL9205115 0.74 OPRM1 (0.50)
SCHEMBL9211873 0.74 OPRM1 (0.50)
SCHEMBL9214274 0.74 OPRM1 (0.50)
SCHEMBL276601 0.74 OPRM1 (0.50)
SCHEMBL9209648 0.74 OPRM1 (0.50)
SCHEMBL11033619 0.74 OPRM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1441 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
EP-1661897-B1 PYRROLOPYRIMIDINONE DERIVATIVE TEIJIN PHARMA LTD (JP) 2013-12-04 EP claimed
US-20110269781-A1 COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-11-03 US claimed
US-7977344-B2 Compounds GLAXOSMITHKLINE LLC (US) 2011-07-12 US claimed
US-7759349-B2 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2010-07-20 US claimed
EP-2125792-A1 PURINE DERIVATIVES AS IMMUNOMODULATORS Smithkline Beecham Corporation (US) 2009-12-02 EP claimed
US-20090131458-A1 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-05-21 US claimed
WO-2008101867-A1 PURINE DERIVATIVES AS IMMUNOMODULATORS SMITHKLINE BEECHAM CORPORATION (US) 2008-08-28 WO claimed
EP-1699799-B1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF IMIDAZO [1,2-B]PYRIDAZINE DERIVATIVES SCHERING PLOUGH LTD (CH) 2007-05-16 EP claimed
EP-1086124-B1 NOVEL CYCLOSPORINS CHEM AG C (CH) 2003-11-19 EP claimed
US-6608033-B1 Treating coccidiosis in bovine animal by administering effective amount of specified azalide macrolide antibiotic PFIZER INC. 2003-08-19 US claimed
US-6583265-B1 Compound for use in the prevention of viral and bacterial infections C-CHEM AG (CH) 2003-06-24 US claimed
EP-1078631-A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis Pfizer Products Inc. (US) 2001-02-28 EP claimed
EP-1002536-A2 2-Amino, 4-alkylamino pyrimidine 3-oxydes as soothing agents for the skin L'OREAL (FR) 2000-05-24 EP claimed
EP-0974586-A1 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same L'OREAL (FR) 2000-01-26 EP claimed
EP-0635508-B1 TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS ASAHI CHEMICAL IND (JP) 1999-10-06 EP claimed
EP-0635508-A1 TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1995-01-25 EP claimed
CN-115916777-B ATX inhibitor and preparation method and application thereof 苏州爱科百发生物医药技术有限公司 2024-07-12 CN disclosed
EP-0004466-A1 Demethyl maytansinoids and methods for producing them Takeda Chemical Industries, Ltd. (JP) 1979-10-03 EP disclosed
US-3951640-A HERBICIDES VELSICOL CHEMICAL CORPORATION (US) 1976-04-20 US disclosed